We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+1.55%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$1.06T
AUM Growth
-$16.9B
Cap. Flow
-$16.2B
Cap. Flow %
-1.53%
Top 10 Hldgs %
26.1%
Holding
3,048
New
131
Increased
1,029
Reduced
1,524
Closed
112

Top Buys

Rank Stock Value
1
XYZ
Block Inc
XYZ
+$2.39B
2
CVNA icon
Carvana
CVNA
+$1.82B
3
MSFT icon
Microsoft
MSFT
+$1.5B
4
DIS icon
Walt Disney
DIS
+$1.25B
5
SPOT icon
Spotify
SPOT
+$1.05B

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$2.65B
2
INTU icon
Intuit
INTU
+$2.08B
3
MTCH icon
Match Group
MTCH
+$1.87B
4
CRM icon
Salesforce
CRM
+$1.76B
5
META icon
Meta Platforms (Facebook)
META
+$1.61B

Sector Composition

Rank Sector Weight
1 Technology 25.08%
2 Healthcare 16.24%
3 Consumer Discretionary 15.33%
4 Communication Services 13.82%
5 Financials 12.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AQB icon
2751
AquaBounty Technologies
AQB
$7.31M
$165K ﹤0.01%
2,032
HDSN
2752
Hudson Technologies
HDSN
$240M
$163K ﹤0.01%
46,060
IBIO icon
2753
iBio
IBIO
$71M
$162K ﹤0.01%
305
ORGO icon
2754
Organogenesis Holdings
ORGO
$232M
$162K ﹤0.01%
11,364
BFLY icon
2755
Butterfly Network
BFLY
$2.47B
$160K ﹤0.01%
+15,294
New +$177K
ENZ
2756
DELISTED
Enzo Biochem, Inc.
ENZ
$159K ﹤0.01%
44,800
RMTI icon
2757
Rockwell Medical
RMTI
$29M
$158K ﹤0.01%
2,417
XERS icon
2758
Xeris Biopharma Holdings
XERS
$1.55B
$158K ﹤0.01%
64,400
+7,500
+13% +$21.8K
XBIT icon
2759
XBiotech
XBIT
$71.3M
$157K ﹤0.01%
12,154
GNE icon
2760
Genie Energy
GNE
$384M
$156K ﹤0.01%
23,842
CIA icon
2761
Citizens
CIA
$201M
$153K ﹤0.01%
24,685
ETWO
2762
DELISTED
E2open Parent Holdings
ETWO
$153K ﹤0.01%
+13,574
New +$152K
VTGN icon
2763
VistaGen Therapeutics
VTGN
$11.6M
$153K ﹤0.01%
1,862
-30
-2% -$2.61K
GROW icon
2764
US Global Investors
GROW
$38.9M
$152K ﹤0.01%
26,700
+8,100
+44% +$48.4K
IZEA icon
2765
IZEA Worldwide
IZEA
$53.4M
$152K ﹤0.01%
19,750
+4,625
+31% +$40.5K
KDNY
2766
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$152K ﹤0.01%
+11,893
New +$157K
VIPS icon
2767
Vipshop
VIPS
$6.75B
$151K ﹤0.01%
13,539
-2,400,844
-99% -$37.7M
BHR
2768
Braemar Hotels & Resorts
BHR
$140M
$150K ﹤0.01%
30,833
+600
+2% +$3.13K
TAST
2769
DELISTED
Carrols Restaurant Group, Inc.
TAST
$141K ﹤0.01%
38,441
-200
-0.5% -$893
GORO icon
2770
Goldgroup Mining Inc.
GORO
$210M
$140K ﹤0.01%
89,460
NUVB icon
2771
Nuvation Bio
NUVB
$2.22B
$140K ﹤0.01%
14,076
+2,593
+23% +$23.5K
AIXC
2772
AIxCrypto Holdings Inc
AIXC
$14.9M
$140K ﹤0.01%
215
SLCA
2773
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$140K ﹤0.01%
17,538
-3,800
-18% -$35.9K
STEX
2774
Streamex Corp
STEX
$89.4M
$139K ﹤0.01%
4,660
CMCT
2775
Creative Media & Community Trust
CMCT
$14.8M
$138K ﹤0.01%
1

Similar funds

T. Rowe Price Associates's Q3 2021 Portfolio in Review

As of Q3 2021, T. Rowe Price Associates held 3,048 positions worth $1.06T, down 1.6% from $1.08T the previous quarter. Its ten largest holdings account for 26% of the portfolio.

T. Rowe Price Associates's Q3 2021 filing shows 131 new, 1,029 increased, 1,524 reduced and 112 closed positions. Its largest new stake was Warby Parker: 17,643,113 shares worth $936M. The largest sale was Visa, an estimated $2.65B.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q3 2021 buy was Warby Parker: 17,643,113 shares worth $936M.
  • T. Rowe Price Associates added most to Block Inc in Q3 2021, an estimated $2.39B increase.
  • T. Rowe Price Associates's biggest Q3 2021 reduction was Visa, cutting an estimated $2.65B.
  • T. Rowe Price Associates fully exited Maxim Integrated Products in Q3 2021, selling an estimated $394M.
  • T. Rowe Price Associates's ten largest holdings make up 26% of its $1.06T portfolio in Q3 2021.
  • T. Rowe Price Associates opened 131 new positions and closed 112 in Q3 2021.
  • T. Rowe Price Associates's portfolio value fell 1.6% quarter-over-quarter to $1.06T.

Based on T. Rowe Price Associates's 13F filing for Q3 2021, filed 15 Nov 2021.